Leo Zeff: The Secret Chief of Psychedelic Therapy

Overview: The resurgence of psychedelic research highlights their therapeutic potential, but the roots of psychedelic therapy date back decades. Leo Zeff, a pioneer in the field, explored LSD, mescaline, and later MDMA, developing innovative therapy protocols. His efforts, though clandestine due to legal constraints, paved the way for integrating psychedelics into therapy. Zeff's warmth and wisdom, remembered fondly by peers like Terence McKenna, underscored his profound impact on the field, now validated by modern research.

‍

The Revival of Psychedelic Therapy

There has been a resurgence of interest in psychedelic research in recent years, aptly termed the psychedelic renaissance. This revival is marked by a growing body of clinical trials demonstrating the therapeutic potential of psychedelics when combined with therapy in carefully controlled contexts.

‍

However, the roots of psychedelic therapy stretch back many decades. Despite heavy prohibition and criminalization in the 1960s and 70s, a cohort of courageous researchers and therapists began exploring psychedelics and offering underground psychedelic-assisted therapies long before the current resurgence.

‍

Among these trailblazers was the American psychologist and psychotherapist Leo Zeff, who pioneered various psychedelic drug-assisted therapies with his patients.

‍

Early Career and Introduction to Psychedelic Therapy

Leo Zeff (May 14, 1912 - April 13, 1988) carved a unique path in the field of psychology and psychotherapy, leaving an indelible mark on the landscape of mental health treatment. After serving as a lieutenant colonel in the U.S Army, Zeff was among the first individuals to attain a Ph.D. in psychology in the state of California.  

‍

Initially specializing in Jungian psychology, Zeff established himself as a respected therapist through years of private practice. However, his professional journey took a drastic turn when, in 1961, he was introduced to the classic psychedelic compound LSD (lysergic acid diethylamide). The powerful effects of LSD, discovered by the German chemist Albert Hofmann in 1943, captivated Zeff’s curiosity and opened new doors of exploration.

‍

Alongside LSD, Zeff also explored the mind-altering properties of mescaline, the active ingredient in psychedelic plants such as peyote and San Pedro cacti, and the inspiration for philosopher Aldous Huxley’s famous 1954 essay, ‘The Doors of Perception.’ These experiences deepened Zeff's self-awareness and revealed the therapeutic potential of psychedelics in his clinical work.

‍

Convinced of their utility as adjuncts to therapy, Zeff transitioned away from traditional therapeutic approaches to focus on the study and application of psychedelic-assisted therapy.

‍

After possession of LSD was banned in the U.S. on October 6, 1966, Zeff continued his work underground, refining techniques and procedures for psychedelic therapy. His dedication attracted a growing clientele eager to explore the transformative potential of this new therapeutic modality.

‍

In the mid-1960s, Zeff's exploration expanded to include MDA (3,4-methylenedioxyamphetamine), a derivative of mescaline introduced to him by chemist Tony Sargent, an associate of the legendary chemist Alexander “Sasha” Shulgin. Throughout the 1960s and 1970s, Zeff remained at the forefront of psychedelic therapy, pushing boundaries and advocating for its recognition and integration within the field of psychotherapy. 

‍

Zeff's Introduction to MDMA

In 1976, Alexander Shulgin reached out to Zeff with exciting news: a new substance had entered the scene, one that, according to Shulgin, held particular promise as a therapeutic. This substance was MDMA (3,4-Methylenedioxymethamphetamine), still legal at the time and yet to garner the attention it would in later years.

‍

Upon experiencing the fear-reducing, empathy-promoting effects of MDMA firsthand, Zeff's retirement plans were put on hold as he delved into a new chapter of his career. He began conducting MDMA sessions focused on personal and spiritual development, captivated by the potential for healing and transformation that this compound, also called “ecstasy,” harbored.

‍

Zeff shared his enthusiasm for MDMA with fellow therapists across the United States. Over the course of 12 years, he administered MDMA to approximately 4000 people and trained over 150 therapists, leading many to endearingly label him as “the Johnny Appleseed of MDMA.”

‍

Not content with merely introducing MDMA to the therapeutic community, Zeff bestowed upon it a symbolic name: “Adam.” This moniker, inspired by the biblical narrative of the Garden of Eden, was intended to encapsulate the essence of MDMA experiences — a return to a state of primal innocence and unity with all life.

‍

In her book ‘Ecstasy: The Complete Guide,’ Dr. Julie Holland reflects on the significance of this MDMA “codename,” highlighting the common themes of innocence, connectedness, and bonding with the natural world that characterize MDMA-induced states. She writes:

‍

“Feelings of being returned to a natural state of innocence, before guilt, shame, and unworthiness arose are common in these Adam-like ecstasies, and so are feelings of connectedness and bonding with fellow human beings, animals, plants, and all the forms and energies of the natural world.”

‍

Zeff’s efforts in popularizing the remarkable properties of MDMA paved the way for its integration into psychotherapeutic practices. 

‍

‍

Zeff's Unique Approach to MDMA-Assisted Therapy

With a keen eye for innovation, Zeff developed revolutionary protocols for psychedelic therapy. His therapy groups followed a structured format, typically beginning with a Friday night session where participants gathered in a talking circle to share their experiences and concerns.

‍

Zeff would then outline specific instructions and agreements designed to create a safe and supportive environment for the MDMA sessions ahead. These agreements emphasized the importance of staying on-site, refraining from harmful or aggressive behavior, and avoiding sexual contact.

‍

During the sessions, Zeff prompted participants to focus on their inner experiences. Using eye shades and headphones, he encouraged a full immersion into their MDMA journey, minimizing external distractions and fostering deep introspection. Sometimes, patients would seek comfort and connection through hugging, which Zeff allowed, before gently guiding them back to their seats.

‍

In his conversations with author Myron Stolaroff, documented in the 1997 book ‘The Secret Chief’ (a nickname given to Zeff by his friend, the psychedelic philosopher Terence McKenna, the circumstances surrounding which are outlined below), Zeff emphasized the importance of surrendering to the experience, advising participants to “lay down and stay down” until they had fully embraced the journey within.

‍

He also recognized the transformative power of music in psychedelic therapy, often encouraging clients to use it as a guiding force during their sessions. As he aptly put it, 

‍

“If you don’t know what to do and your mind wanders, then listen to the music. If you go into heavy judgments against yourself, then listen to the music.”

‍

Following the MDMA sessions, Zeff facilitated a ritualized integration circle where participants shared their insights and experiences, allowing for reflection and communal support. This practice of integration was a crucial element of the therapeutic process, helping individuals make sense of their journey and incorporate their newfound insights into their lives.

‍

Operating under pseudonyms due to the illegality of his work, Zeff remained a hidden figure for many years. It wasn't until the re-release of ‘The Secret Chief’ in 2004 — ‘The Secret Chief Revealed’ — that the wider world would learn of his real name.  

‍

In ‘The Secret Chief Revealed’, Zeff not only shares his personal experiences with psychedelic substances, but he also underscores the therapeutic potential of psychedelic-assisted therapy, even at a time when their use was confronted by strict legal constraints. He emphasizes how psychedelics can dismantle psychological barriers, help to mend relationships, and free people from rigid patterns of thinking and behaving.

‍

Zeff's conversations with Stolaroff also shed light on the obstacles psychedelics faced in the latter half of the 20th century, largely due to sensationalized media coverage that overshadowed their therapeutic value.

‍

Celebrating The Secret Chief 

‘The Secret Chief Revealed’ provides wonderful insights into what Leo Zeff was like as a person. By all accounts, he had a great sense of humor, a tremendous appetite for life, infectious vitality, and was fiercely liked and respected by his peers. Terence McKenna, speaking at a memorial service held for Zeff in 1988, eloquently captured this sentiment:

‍

“I felt when I stood near Leo, that I stood near a giant. And what the experience of standing near a giant was, was the experience of the wisest, kindest, gentlest, funniest man that I have ever had the privilege to know.”

‍

McKenna goes on to share a touching anecdote illustrating Zeff's warm nature:

‍

“I said ‘Leo, I want to ride in your canoe. I don't care where you're going, I just want to be in your canoe,’ and he said, ‘You're always welcome in my canoe.’”

‍

McKenna felt as though he had been inducted into Zeff's “tribe, Leo's people,” for whom Leo was their “secret chief.” He believed that Zeff possessed an intimate understanding of “psychology and healing of the soul,” in which the importance of letting the psyche grow and flower according to its own rules was emphasized. 

‍

Zeff's legacy extends beyond memorable impressions left on friends; he played a pivotal role in introducing clients and therapists to the benefits of using psychedelics for therapeutic purposes, as well as for personal growth and the betterment of well people. Firm in his conviction, Zeff believed that substances like MDMA were immensely beneficial when used properly.

‍

Decades later, modern research is validating his beliefs, proving him right in his pioneering efforts and belief in the field of psychedelic therapy.